Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

iSpecimen (ISPC) Current Deferred Revenue: 2020-2024

Historic Current Deferred Revenue for iSpecimen (ISPC) over the last 5 years, with Dec 2024 value amounting to $360,708.

  • iSpecimen's Current Deferred Revenue fell 45.16% to $155,506 in Q3 2025 from the same period last year, while for Sep 2025 it was $155,506, marking a year-over-year decrease of 45.16%. This contributed to the annual value of $360,708 for FY2024, which is 13.24% down from last year.
  • Latest data reveals that iSpecimen reported Current Deferred Revenue of $360,708 as of FY2024, which was down 13.24% from $415,771 recorded in FY2023.
  • In the past 5 years, iSpecimen's Current Deferred Revenue registered a high of $873,254 during FY2020, and its lowest value of $132,335 during FY2022.
  • Its 3-year average for Current Deferred Revenue is $302,938, with a median of $360,708 in 2024.
  • In the last 5 years, iSpecimen's Current Deferred Revenue slumped by 79.79% in 2022 and then soared by 214.18% in 2023.
  • iSpecimen's Current Deferred Revenue (Yearly) stood at $873,254 in 2020, then dropped by 25.02% to $654,746 in 2021, then plummeted by 79.79% to $132,335 in 2022, then surged by 214.18% to $415,771 in 2023, then declined by 13.24% to $360,708 in 2024.